Skip to main content


In 2021, the neurostimulation devices market size was $6,095.2 million, and it is predicted to advance at a 9.9% CAGR from 2021 to 2030, to hit $14,239.5 million in 2030. Neurostimulation equipment is generally used to cure chronic pain and neurological problems by inducing tingling sensations in the injured nerve. Moreover, these devices are inserted surgically inside the brain, to create paresthesia, a tingling sensation in the nerve, at preprogrammed intervals. Such electrical sensations cause the wounded neurons to ‘feel’ and help in the treatment of neurological problems and chronic pain.